Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma

Despite of the discovery of protein therapeutic targets and advancement in multimodal therapy, the survival chance of high-risk neuroblastoma (NB) patients is still less than 50%. MYCN amplification is a potent driver of NB, which exerts its oncogenic activity through either activating or inhibiting...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncotarget
मुख्य लेखकों: Sahu, Divya, Hsu, Chia-Lang, Lin, Chen-Ching, Yang, Tz-Wen, Hsu, Wen-Ming, Ho, Shinn-Ying, Juan, Hsueh-Fen, Huang, Hsuan-Cheng
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Impact Journals LLC 2016
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295409/
https://ncbi.nlm.nih.gov/pubmed/27517149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11158
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन